When purchasing, its essential to ensure that the product is clearly labeled for research use only , is backed by third-party testing, and is sourced from suppliers with transparent manufacturing practices
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
ract (Curcuma long) (root)
For most, the great decision theyre going to make comes down to what suits their health requirements and goals
Rapid weight loss changes estrogen levels, and the hormonal shifts that accompany significant fat loss can temporarily alter cycle timing, flow, and symptoms
June 2025: A 2025 study published in JAMA Ophthalmology has found a connection between taking tirzepatide drugs like Mounjaro and developing NAION